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Abstract 
In this position paper, we review definitions related to this subject and the corresponding 
literature. Our recommendations include the following statements. Asymptomatic bacteriuria, 
asymptomatic leukocyturia, urine discolouration, odd smell or positive nitrite sediments are not an 
indication for antimicrobial treatment. Antimicrobial treatment of asymptomatic bacteriuria does 
not prevent periprosthetic joint infection, but is associated with adverse events, costs and 
antibiotic resistance development. Urine analyses or urine cultures in asymptomatic patients 
undergoing orthopaedic implants should be avoided. Indwelling urinary catheters are the most 
frequent reason for healthcare-associated urinary tract infections and should be avoided or 
removed as soon as possible. 
Key words: Asymptomatic bacteriuria, asymptomatic leukocyturia, urine discolouration 
Introduction 
Periprosthetic joint infection (PJI) is a serious 
complication after arthroplasty. The relationship 
between abnormal results in urine analysis and 
potential risk for PJI often raises questions about the 
optimal management in patients undergoing surgery 
for joint replacement 
In this position paper, we review definitions 
related to this subject and the corresponding 
literature. These recommendations reflect the 
opinions of the expert group ‘Infection’ of 
swissorthopaedics, the Swiss Society of Orthopaedics 
and Traumatology (http://www.swissorthopaedics. 
ch). 
Definitions 
Before reviewing the relation between abnormal 
urinary results and the risk for PJI, commonly used 
terms should be defined. The definitions of 
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bacteriuria, pyuria, leukocyturia, asymptomatic 
bacteriuria (ASB) and symptomatic lower urinary 
tract infection (UTI) are presented in table 1 (1, 2). The 
method of obtaining the urine specimen matters for 
the definition of ASB. If the methods of obtaining 
urine samples are not consistent, it suggests an 
accuracy problem for this variable when comparing 
studies. Details of urinary sampling methods, the 
subject of complicated UTI, antibiotic treatment of 
symptomatic UTI, and pyelonephritis are discussed 
elsewhere (3), and are beyond the scope of this 
document. The 2014 recommendations of the Swiss 
Society for Infectious Diseases regarding the 
treatment of UTI are available on the society’s 
website (1). 
Leukocyturia/pyuria 
The differentiation between ‘leukocyturia’ and 
‘pyuria’ is not common in clinical practice (table 1). In 
this document, we prefer to use the term 
‘leukocyturia’. It is frequently found in ASB and in 
other conditions associated with inflammation of the 
genitourinary tact (2, 4). The presence alone, or in 
association with nitrite positive sediments or 
dark-coloured urine is not reason enough to perform 
a urine culture or to treat an asymptomatic patient 
with a positive urine culture result. In other words, 
leukocyturia indicates an inflammation in the 
genitourinary tract but not necessarily an infection 
(low positive predictive value). In contrast, absence of 
leukocyturia does not rule out urinary tract infection 
(4-6). 
Asymptomatic bacteriuria is common 
ASB is very common. Its reported prevalence is 
higher in older persons, in women, and in the 
presence of genitourinary abnormalities (2, 7). The 
prevalence of ASB in a general hospital population on 
the day of admission was recently reported to be 8.5% 
(8). In diabetic adults and community-dwelling 
elderly adults, rates of up to 50% or more, have been 
published (reviewed in (9)). In patients with a chronic 
indwelling urinary catheter, the rate of ASB is even 
higher (e.g., up to 100%, reviewed in (10)(11)). 
Treatment of ASB in patients undergoing 
surgery for joint replacement 
In previous decades, various orthopaedic centres 
reported their practice of antimicrobial treatment for 
preoperatively detected ASB. In these centres, no 
postoperative haematogenous seeding of bacteria to 
the artificial joint was observed (12-14). This finding 
led to the rationale to screen urine preoperatively and, 
upon detection of bacterial growth, to treat ASB with 
antibiotics in patients who were undergoing surgery 
for joint replacement (15, 16). In addition, surgical 
intervention was often delayed or, alternatively, an 8- 
to 10-day postoperative course of oral antibiotics was 
recommended (16, 17). From today’s perspective and 
in our view, this rational is not correct, as outlined 
with following data. 
In 1987, a prospective study on 227 patients 
undergoing hip or knee replacement found no 
correlation between PJI and urinary tract infection 
(18). In 2009, Koulouvaris et al. examined the medical 
records of 19’735 patients (19). The authors found no 
association between preoperative or postoperative 
UTI and surgical site infection. The power of the 
study was low, mainly because the PJI rate was low 
(0.29%). Nonetheless, this points towards a very low 
risk of haematogenous seeding of microorganism 
from the urinary tract to the newly implanted artificial 
joint. This statement is supported by results from 
Uçkay et al. (11). In their retrospective study, the 
cumulative duration of estimated urinary tract 
bacterial colonization for 6’101 total joint 
arthroplasties patients was approximately 120’000 
patient-days (median duration 295 days). In this 
patient population no immediate haematogenous 
seeding from the urinary tract to the newly implant 
was observed (11). 
After 2013, studies performed in Spain (20, 21), 
in Switzerland (22), and a multinational collaboration 
study (Portugal, Spain, United Kingdom) (23) 
questioned the benefit of treating ASB. These studies 
included 215 (21), 471 (20), 510 (22) and 2497 (23) 
patients, respectively, and the results of these 
investigations were similar. First, in the few PJIs that 
occurred postoperatively, the organism that caused 
the infection was different from that cultured in the 
preoperatively obtained urine. Second, antimicrobial 
treatment of ASB did not effectively result in a sterile 
postoperative urine culture but in change of cultured 
organisms. For example in the Swiss study, 
perioperative prophylaxis with cefuroxime changed 
the culture results from Gram-negative to 
Gram-positive organisms in 50% of asymptomatic 
patients (22). Third, lack of antibiotic treatment for 
ASB was not associated with a higher risk of 
postoperative PJI due to a microorganism previously 
found in the urine or a higher risk of postoperative 
symptomatic UTI. These findings are in line with 
results from large meta-analyses showing no 
differences between antibiotic treatment and no 
treatment of ASB for the development of symptomatic 
UTI (24). 
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Table 1. Definitions for terms used to describe abnormal findings in urine analysis. 
Term Description Definition Details 
Bacteriuria Presence of bacteria in urine; density is 
expressed as colony forming units (cfu) 
organism per millilitre (mL) 
Presence or absence of symptoms must be 
determined 
 
Variables for the definition: 
method of sampling 
number of specimens 
cfu organism /mL 
gender 
Asymptomatic bacteriuria 
  
  
 
Isolation of a specified quantitative count 
of bacteria in an appropriately collected 
urine specimen obtained from a person 
without symptoms or signs referable to 
urinary infection 
≥105 cfu of the same organism/mL in 2 
consecutive clean voided urine specimens 
(midstream) for women, or 1 specimen 
(midstream) for men 
 
If urine is obtained via catheterization, 
definition includes ≥102 cfu organism/mL in 
1 specimen. 
In persons with indwelling urinary catheter, 
≥103 cfu organism/mL in 1 specimen. 
Pyuria 
 
Presence of increased numbers of PMN* 
leukocytes in urine 
No uniformly accepted definition (e.g., 
≥103 WBC*/mL in non-centrifuged urine). 
Often referred to as marked leukocyturia 
Terms pyuria and leukocyturia often used 
interchangeably 
Leukocyturia Presence of (undifferentiated) leukocytes 
in urine 
≥10 leukocytes per microscopic field or 
positive leukocyte esterase result in a 
reagent strip test 
The cut-off (number of leukocytes per 
microscopic field) can vary between 
laboratories 
Acute uncomplicated 
urinary tract infection in 
women 
 
A symptomatic bladder infection 
characterized by frequency, urgency, 
dysuria or suprapubic pain in a woman 
with a normal urinary tract 
≥102 cfu/mL organism in voided urine or 
via catheterization obtained in urine from 
1 specimen. In persons with indwelling 
urinary catheter, ≥103 cfu organism/mL in 
1 specimen. 
Absence of pain and tenderness in the 
costovertebral angle, no fever, no 
bacteraemia, no functional or structural 
abnormalities of the genitourinary tract 
* PMN, polymorphonuclear; WBC, white blood cells 
 
 
The data indicates, however, that the presence of 
ASB prior to surgery has no clinical relevance, and 
therefore, should neither indicate preoperative 
antimicrobial treatment, nor delay surgery, nor lead 
to prescription of postoperative antibiotics. Also, 
routine perioperative antibiotic prophylaxis should 
not be switched to a compound active against 
microorganisms found in the urine of patients with 
ASB. Cordero-Ampuero et al. (20) randomly assigned 
patients undergoing surgery for total hip arthroplasty 
or hemiarthroplasty and with ASB to receive specific 
antibiotics (n = 117) or routine antibiotic prophylaxis 
(n = 126). Thirteen patients developed PJI after 3 
months. Bacteria cultured from the wound were not 
those cultured in urine samples in any case, 
irrespective of the previous choice of antimicrobial 
compound.  
In the work by Sousa et al. (23), the presence of 
ASB was associated with a higher risk for PJI, 
irrespective of organisms found in the urine. In our 
view, the interpretation of this finding falls into the 
category of weighting patients’ comorbidities for 
postoperative complications, including infections. In 
other words, a wide range of patient-related factors 
increases the risk of surgical site infections (25, 26). 
Sousa et al. (23) and the accompanying editorial note 
by Duncan (27) suggested that ASB may also be a 
surrogate marker for increased risk of infection, but 
not a risk factor itself. In other words, the study 
suggests an epidemiological association but not a 
causal relation between ASB and development of a PJI 
of a non-urinary origin (28).  
Many of the cited studies face the criticism of 
being underpowered. Indeed, Bouvet et al. (22) 
calculated a sample size of 2 x 50’979 arthroplasties 
for a superiority trial (α 0.05, power 80%, difference in 
infection risk 0.15%) and approximately 2 x 200’000 
for a non-inferiority trial. It is not realistic that such a 
trial will ever be performed. However, Bouvet et al. 
(22) evaluated the costs associated with the screening 
and treatment for ASB (Geneva, Switzerland). On the 
basis of 510 elective arthroplasties performed in one 
year, the estimated minimal laboratory costs for 
preoperative urinary analyses were 25’000 Swiss 
Francs. The estimated savings by withholding 
antibiotics for ASB were at least 2’000 Swiss Francs 
(22). Understandably, this cost estimate will be likely 
higher when ASB with multi-drug-resistant bacteria 
are treated. 
The power calculation is also important to 
highlight collateral damages caused by unnecessary 
use of antibiotics. Antibiotic treatment for ASB is 
associated with significantly more adverse events and 
the development of resistance (24, 29). Unfortunately, 
ASB has become a major cause of inappropriate 
antimicrobial use (30, 31). This reasoning coincides 
with epidemiological data showing that the rate of 
ASB is higher in older persons and in the presence of 
genitourinary abnormalities (2, 32). Evidently, these 
patient groups overlap with those requiring 
arthroplasty for osteoarthritis.  
Based on these arguments, we do not 
recommend urine analyses in asymptomatic patients 
undergoing surgery for orthopaedic implants. Our 
recommendation is valid for all asymptomatic 
patients regardless of gender, age, local urologic 
cancer or chronic urinary catheter use. We also 
support this recommendation for patients treated 
with immunosuppressive compounds, although few 
data on PJI are available for this patient population. 
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The rational for this recommendation is based on the 
observation of similar low PJI rates due to 
Gram-negative rods or enterococci (i.e., 
microorganisms typically found in the urine) in the 
general population (33, 34) and in a nested survey 
within the Swiss Transplant Cohort Study (Ilker Uçkay, 
Andrey Diego, unpublished data). Similarly, Vergidis et 
al. (35) retrospectively reviewed the arthroplasty 
cohort of the Mayo Clinic. Among 367 solid organ 
transplant patients, 12 PJIs were identified. Eight of 
them were caused by staphylococci and streptococci, 
two by nontuberculous mycobacteria, and two cases 
were culture-negative. Only one co-infection with 
Klebsiella spp. (0.27%) among all transplant patients 
was found. 
If a urinary culture is nonetheless performed, a 
positive result should not be treated in asymptomatic 
patients. The routine perioperative antibiotic 
prophylaxis should not be modified. Moreover, the 
results, including the presence of leukocyturia, urine 
decolouration, odd smell or positive nitrite sediments 
should not lead to postponement of the surgical 
intervention (36). 
Symptomatic bacteriuria/urinary tract 
infection 
The diagnosis and treatment of UTIs is discussed 
elsewhere (37, 38). Guideline recommendations for 
the treatment of UTI vary between countries and 
institutions on the basis of local resistance 
epidemiology and results from surveillance systems. 
The 2014 recommendations of the Swiss Society for 
Infectious Diseases regarding the treatment of UTI are 
available on the society’s website (1). The decision to 
perform surgery after a UTI has been identified 
preoperatively depends on the extent of infection and 
the timing of surgery. In patients with signs of sepsis 
(e.g., urosepsis or positive blood cultures), a delay of 
surgery is recommended until the infection is 
controlled. Such a recommendation is, however, less 
clear for uncomplicated cystitis without sepsis. In our 
view, it is not necessary to postpone surgery, though 
antimicrobial treatment for UTI must be initiated 
promptly. The scientific rational for this opinion 
statement however remains to be elaborated. In these 
cases, treatment recommendations do not differ from 
those for UTI in other patients (1). This is also true for 
postoperative UTI. 
Prevention of postoperative urinary tract 
infection 
There are conflicting results about whether 
postoperative UTI is a risk factor for PJI. While several 
studies have suggested that postoperative UTI is 
indeed a risk factor for PJI (26, 39), a recent review and 
meta-analysis did not confirm this hypothesis (40). 
Because the precise definitions of UTIs in these large 
data analyses are frequently missing, the 
interpretation of the results becomes ambiguous. 
Nonetheless, healthcare-associated infection, 
including symptomatic UTI after joint replacement, 
must be avoided.  
The presence of a urinary catheter is the most 
important risk factor for healthcare-associated UTI 
(41). Indwelling urinary catheters in place for ≥2 days 
result in a significant increase in nosocomial 
infections (42). Thus, infection control strategies to 
prevent UTI are pivotal for every orthopaedic centre. 
Stéphan et al. (43) demonstrated that multifaceted 
interventions after orthopaedic surgery led to a 
reduction in the number of UTIs to two-thirds of that 
in the control group. These interventions included 
restricting urinary catheterization to a defined patient 
group, inserting catheters by using aseptic techniques 
and sterile equipment, connecting catheters to a 
closed drainage system, and removing the urinary 
catheter (if insertion was necessary at all) before 
patient discharge from the postanaesthesia care unit 
(43). In addition, specifically tailored, locally 
developed guidelines were distributed; educational 
sessions were performed; and posters with a visual 
display of the guidelines were hung up. Guidelines 
were applied in the operating room, postanaesthesia 
care unit and surgical ward (43). These combined 
efforts demonstrate the multidisciplinary need to 
implement prevention strategies. It is important to 
maintain a suitable educational level in order to 
sustain the high success rate of such interventions 
(44). This level can be achieved by engaging local 
leaders or a multidisciplinary team who are in 
decision-making positions (44).  
Conclusions 
For ASB, a paradigm shift from treatment to 
non-treatment has occurred in recent years. Treating 
ASB does more harm than good and should be 
avoided. In addition, the presence of ASB should not 
postpone surgery. Perioperative antibiotic 
prophylaxis should not be modified because of ASB. 
This recommendation is equally valid for the presence 
of asymptomatic leukocyturia or positive nitrite 
sediments. 
The most common risk factors for postoperative 
healthcare-associated UTIs are indwelling urinary 
catheters. They should be indicated for only a few 
patient groups and removed as rapidly as possible. 
Preventive strategies require a multifaceted approach 
and constant engagement by all involved parties.  
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